Synvisc One

Synvisc One is an FDA-approved solution for joint pain relief, particularly in individuals with osteoarthritis. It offers a single-injection viscosupplement therapy that effectively alleviates knee pain by replenishing hyaluronic acid in the joint, reducing friction, and enhancing joint mobility. This innovative treatment provides up to six months of pain relief, making it a convenient and cost-effective option. Synvisc One is safe and minimizes the need for multiple injections, offering patients extended relief without the burden of frequent treatments.

The Packaging Content:

• 1 x 6ml per syringes

Composition:

• Hylan polymers (Hylan A + Hylan B) 48 mg
• Sodium chloride 51 mg
• Disodium hydrogen phosphate 0.96 mg
• Sodium dihydrogen phosphate monohydrate 0.24 mg
• Water for injection q.s. to 6.0 mg

Benefits:

• Long-lasting pain relief
• Improved joint function and mobility
• Cushions and lubricates the knee joint
• Delays the need for knee replacement surgery
• Supported by extensive research and clinical studies
• Favorable safety profile and high tolerability